SCHEMBL3846485

SCHEMBL3846485

COc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2Br)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.45
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
NPC1 O15118 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 2/20 0.45
L3MBTL1 Q9Y468 3/20 0.43
LMNA P02545 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HTT P42858 1/20 0.42
NLRP3 Q96P20 1/20 0.42
ATM Q13315 1/20 0.42
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
AURKA O14965 1/20 0.39
TP53 P04637 1/20 0.39
EGFR P00533 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL519563 0.85 KDM4E (0.36) RAB9AKDM4EALDH1A1MEN1KMT2A
SCHEMBL3848485 0.85 MEN1 (0.42) RAB9AKDM4EALDH1A1MEN1KMT2A
SCHEMBL3845929 0.84 PTGS2 (0.36) RAB9AKDM4EALDH1A1NPC1MAPT
SCHEMBL3850830 0.83 L3MBTL1 (0.46) RAB9AKDM4EALDH1A1MEN1KMT2A
SCHEMBL3849059 0.83 KDR (0.42) MEN1KMT2ANPC1LMNA
SCHEMBL3846335 0.82 KDR (0.38) MEN1KMT2AL3MBTL1
SCHEMBL3846787 0.82 POLB (0.39) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3849213 0.82 CYP3A4 (0.36) RAB9AKDM4EALDH1A1MEN1KMT2A
SCHEMBL3846098 0.82 GAA (0.39) RAB9AKDM4EMEN1KMT2ANPC1
SCHEMBL3848108 0.82 MEN1 (0.46) RAB9AKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed